| Filed On | Filing |
|---|---|
| 23 Oct 2026 |
Form 4: Batchelor Ann-Louise, Group Chief Marketing Officer
Received 12,000 shares as a grant or award |
| 30 Sep 2026 |
Form 4: Forterre Gael, Chief Commercial Officer
Gave up 284 shares to cover exercise price or tax ($71.8) |
| 30 Sep 2026 |
Form 4: Michel Gaetan, Chief Operating Officer
Gave up 608 shares to cover exercise price or tax ($154) |
| 25 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC,... |
| 16 Sep 2026 | SCHEDULE 13D/A |
| 15 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC,... |
| 14 Sep 2026 |
8-K: Other Events
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 |
| 09 Sep 2026 | EFFECT |
| 09 Sep 2026 | FORM S-3/A |
| 08 Sep 2026 | FORM S-3/A |
| 04 Sep 2026 | SCHEDULE 13D |
| 02 Sep 2026 | 8-K: Entry into a Material Definitive Agreement |
| 02 Sep 2026 | 8-K: Unregistered Sales of Equity Securities |
| 28 Aug 2026 | FORM S-3 |
| 24 Aug 2026 | 8-K: Unregistered Sales of Equity Securities |
| 21 Aug 2026 | FORM S-8 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | FORM 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 07 Aug 2026 | 8-K: Unregistered Sales of Equity Securities |
Loading...
